Investigating early treatment options for frontotemporal lobar degeneration.
Project 1
This study is looking for people with genetic changes that could lead to frontotemporal lobar degeneration (FTLD) before they have any symptoms, so we can find ways to start treatment early and possibly slow down or prevent the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10889908 on NIH RePORTER |
What this research studies
This research focuses on frontotemporal lobar degeneration (FTLD), a group of severe neurodegenerative disorders that significantly impact patients and their families. The project aims to identify individuals with genetic mutations linked to FTLD before they show symptoms, allowing for early intervention with potential disease-modifying drugs. By developing reliable markers to predict the onset of symptoms, the research seeks to track the effectiveness of treatments in asymptomatic individuals. This approach could lead to groundbreaking strategies for delaying or preventing the progression of FTLD.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of FTLD or known genetic mutations associated with the disorder.
Not a fit: Patients without a genetic predisposition to FTLD or those already experiencing significant symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier interventions that significantly delay or prevent the onset of dementia in at-risk individuals.
How similar studies have performed: Other research has shown promise in early intervention strategies for neurodegenerative disorders, suggesting that this approach could be effective.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Rosen, Howard J — Mayo Clinic Rochester
- Study coordinator: Rosen, Howard J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.